There is a lack of evidence on impact and cost of new insecticides used for indoor residual spraying (IRS) to protect against malaria. This study analyzed data collected in Southern Province, Zambia to retrospectively evaluate the effectiveness of next-generation IRS, such as Actellic, on malaria incidence and prevalence in Zambia.